Is a complete VOR research report available?

No complete published report is available for Vor Biopharma Inc. (VOR) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Vor Biopharma Inc. (VOR)

NASDAQ: VOR · USD

$20.8

+1.24 (+6.3%)· Recorded snapshot

Market cap	1.2B
Net income (ttm)	627.8M
EPS (ttm)	$20.2
Shares out	59.2M
P/E (trailing)	1.0x
Volume	870,934
Beta	1.78

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): 627.8M
EPS (ttm): $20.2
P/E (trailing): 1.0x
Market cap: 1.2B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Держать

Metric	Value
Amount currency	USD
CIK code	0001817229
Company name	Vor Biopharma Inc.
Country	United States
Country code	US
CUSIP number	929033207
Earnings date	2026-11-12
Earnings time	amc
Employees	76
Employees change	-83
Employees growth	-52.2%
Enterprise value	$766.1M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2015
In index	RUSSELL2000
Industry	Biotechnology
IPO date	2021-02-05
Is primary listing	Yes
Is SPAC	No
ISIN number	US9290332074
Last 10-K release date	2026-03-30
Last earnings date	2026-08-11
Last refreshed	2026-10-28
Last stock split date	2025-09-19
Last stock split type	Reverse
Market cap	$1.2B
Market cap category	Small-Cap
Next earnings date	2026-11-12
Options	Yes
Price	$20.78
Price currency	USD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	VOR
U.S. state	Massachusetts
Website	https://www.vorbio.com

Metric

Value

Amount currency

USD

CIK code

0001817229

Company name

Vor Biopharma Inc.

Country

United States

Country code

CUSIP number

929033207

Earnings date

2026-11-12

Earnings time

amc

Employees

Employees change

-83

Employees growth

-52.2%

Enterprise value

$766.1M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2015

In index

RUSSELL2000

Industry

Biotechnology

IPO date

2021-02-05

Is primary listing

Yes

Is SPAC

ISIN number

US9290332074

Last 10-K release date

2026-03-30

Last earnings date

2026-08-11

Last refreshed

2026-10-28

Last stock split date

2025-09-19

Last stock split type

Reverse

Market cap

$1.2B

Market cap category

Small-Cap

Next earnings date

2026-11-12

Options

Yes

Price

$20.78

Price currency

USD

Sector

Healthcare

SIC code

2836

Stock price date

2026-10-28

Symbol

VOR

U.S. state

Massachusetts

Website

https://www.vorbio.com

Metric	Value
Adjusted P/E ratio	0.11x
Earnings yield	97.17%
EV/Earnings	1.12x
FCF / EV yield	-20.02%
FCF yield	-12.07%
P/E ratio	1.03x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Adjusted P/E ratio

0.11x

Earnings yield

97.17%

EV/Earnings

1.12x

FCF / EV yield

-20.02%

FCF yield

-12.07%

P/E ratio

1.03x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
Profit per employee	$8.3M
ROA	-21.37%
ROA (5Y)	-39.03%
ROCE	-25.73%

Metric

Value

Profit per employee

$8.3M

ROA

-21.37%

ROA (5Y)

-39.03%

ROCE

-25.73%

Metric	Value
EPS growth quarters	3
EPS growth years	0
Net income growth quarters	1
Net income growth years	0
Revenue growth years	0

Metric

Value

EPS growth quarters

EPS growth years

Net income growth quarters

Net income growth years

Revenue growth years

Metric	Value
Capital expenditures	$-726,000
Depreciation and amortization	$89,000
EBIT	$-117.4M
EBITDA	$-117.3M
EPS	$20.19
FCF per share	$-2.38
Financing cash flow	$404.1M
Free cash flow	$-140.8M
Free cash flow minus SBC	$-174.2M
Investing cash flow	$-349M
Net cash flow	$-85M
Net income	$627.8M
Operating cash flow minus SBC	$-173.5M
Operating income	$-117.4M
Stock-based compensation	$33.4M

Metric

Value

Capital expenditures

$-726,000

Depreciation and amortization

$89,000

EBIT

$-117.4M

EBITDA

$-117.3M

EPS

$20.19

FCF per share

$-2.38

Financing cash flow

$404.1M

Free cash flow

$-140.8M

Free cash flow minus SBC

$-174.2M

Investing cash flow

$-349M

Net cash flow

$-85M

Net income

$627.8M

Operating cash flow minus SBC

$-173.5M

Operating income

$-117.4M

Stock-based compensation

$33.4M

Metric	Value
Book value per share	$-3.68
Long-term assets	$5.9M
Long-term liabilities	$656.4M
Net cash (debt)	$463.3M
Net cash / market cap	39.71%
Net cash growth	130.97%
Piotroski F-Score	2
Property, plant and equipment	$3.4M
Shareholders' equity	$-200.2M
Tangible book value	$-200.2M
Tangible book value per share	$-3.68
Total assets	$481.1M
Total cash	$466.1M
Total debt	$2.9M
Total liabilities	$681.3M
WACC	14.02%

Metric

Value

Book value per share

$-3.68

Long-term assets

$5.9M

Long-term liabilities

$656.4M

Net cash (debt)

$463.3M

Net cash / market cap

39.71%

Net cash growth

130.97%

Piotroski F-Score

Property, plant and equipment

$3.4M

Shareholders' equity

$-200.2M

Tangible book value

$-200.2M

Tangible book value per share

$-3.68

Total assets

$481.1M

Total cash

$466.1M

Total debt

$2.9M

Total liabilities

$681.3M

WACC

14.02%

Metric	Value
Current assets	$475.1M
Current liabilities	$24.8M
Current ratio	19.15
Net working capital	$-15.5M
Quick ratio	18.78
Working capital	$450.3M

Metric

Value

Current assets

$475.1M

Current liabilities

$24.8M

Current ratio

19.15

Net working capital

$-15.5M

Quick ratio

18.78

Working capital

$450.3M

Metric	Value
Buyback yield / dilution	-540.03%
Dividend yield	0%
Shareholder yield	-540.03%

Metric

Value

Buyback yield / dilution

-540.03%

Dividend yield

Shareholder yield

-540.03%

Metric	Value
150-day SMA	$18.29
1D price change	6.35%
1M price change	12.2%
1M total return	12.2%
1W price change	9.72%
1W total return	9.72%
1Y price change	-26.13%
1Y return CAGR	-26.14%
1Y total return	-26.13%
20-day SMA	$18.91
200-day SMA	$17.28
3M price change	6.89%
3M total return	6.89%
3Y price change	-50.52%
3Y return CAGR	-20.9%
3Y total return	-50.52%
50-day SMA	$20.87
50-day SMA vs 200-day SMA	50over200
52-week high	$28.66
52-week high date	2025-10-28
52-week low	$6.50
52-week low date	2025-11-20
5Y price change	-93.37%
5Y return CAGR	-41.88%
5Y total return	-93.37%
6M price change	47.17%
6M total return	47.17%
All-time high	$1,272.40
All-time high date	2021-02-05
All-time low	$2.62
All-time low date	2025-05-09
Average true range (ATR)	$1.22
Average volume	795.7K
Beta (1Y)	2.72
Beta (2Y)	5.07
Beta (5Y)	1.78
Change from 52-week high	-27.49%
Change from 52-week low	219.69%
Change from all-time high	-98.37%
Change from all-time low	692.52%
Change from open	7.22%
Day's gap	-0.82%
Dollar volume	$18.1M
High price	$20.80
Low price	$19.38
Monthly RSI	39.72
Open price	$19.38
Position in 52-week range	98.59%
Premarket change	-2.05%
Premarket close	$19.54
Premarket price	$19.14
Premarket volume	6.5K
Previous close	$19.54
Price vs 150-day SMA	13.63%
Price vs 20-day SMA	9.87%
Price vs 200-day SMA	20.29%
Price vs 50-day SMA	-0.44%
Relative volume	1.12
Return from IPO open	-97.65%
Return from IPO price	9.56%
RSI	58.46
Sharpe ratio	0.24
Sharpe ratio (3Y)	0.47
Sharpe ratio (5Y)	0.08
Sortino ratio	0.4
Sortino ratio (3Y)	0.85
Sortino ratio (5Y)	0.19
Volume	870.9K
Weekly RSI	53.89
YTD price change	58.87%
YTD total return	58.87%

Metric

Value

150-day SMA

$18.29

1D price change

6.35%

1M price change

12.2%

1M total return

12.2%

1W price change

9.72%

1W total return

9.72%

1Y price change

-26.13%

1Y return CAGR

-26.14%

1Y total return

-26.13%

20-day SMA

$18.91

200-day SMA

$17.28

3M price change

6.89%

3M total return

6.89%

3Y price change

-50.52%

3Y return CAGR

-20.9%

3Y total return

-50.52%

50-day SMA

$20.87

50-day SMA vs 200-day SMA

50over200

52-week high

$28.66

52-week high date

2025-10-28

52-week low

$6.50

52-week low date

2025-11-20

5Y price change

-93.37%

5Y return CAGR

-41.88%

5Y total return

-93.37%

6M price change

47.17%

6M total return

47.17%

All-time high

$1,272.40

All-time high date

2021-02-05

All-time low

$2.62

All-time low date

2025-05-09

Average true range (ATR)

$1.22

Average volume

795.7K

Beta (1Y)

2.72

Beta (2Y)

5.07

Beta (5Y)

1.78

Change from 52-week high

-27.49%

Change from 52-week low

219.69%

Change from all-time high

-98.37%

Change from all-time low

692.52%

Change from open

7.22%

Day's gap

-0.82%

Dollar volume

$18.1M

High price

$20.80

Low price

$19.38

Monthly RSI

39.72

Open price

$19.38

Position in 52-week range

98.59%

Premarket change

-2.05%

Premarket close

$19.54

Premarket price

$19.14

Premarket volume

6.5K

Previous close

$19.54

Price vs 150-day SMA

13.63%

Price vs 20-day SMA

9.87%

Price vs 200-day SMA

20.29%

Price vs 50-day SMA

-0.44%

Relative volume

1.12

Return from IPO open

-97.65%

Return from IPO price

9.56%

RSI

58.46

Sharpe ratio

0.24

Sharpe ratio (3Y)

0.47

Sharpe ratio (5Y)

0.08

Sortino ratio

0.4

Sortino ratio (3Y)

0.85

Sortino ratio (5Y)

0.19

Volume

870.9K

Weekly RSI

53.89

YTD price change

58.87%

YTD total return

58.87%

Metric	Value
Float	37.2M
Float percentage	62.93%
Shares change (QoQ)	26.26%
Shares change (YoY)	540.03%
Shares held by insiders	2%
Shares held by institutions	63.25%
Shares outstanding	59.2M
Short % of float	20.99%
Short % of shares	13.21%
Short ratio	6.1 days

Metric

Value

Float

37.2M

Float percentage

62.93%

Shares change (QoQ)

26.26%

Shares change (YoY)

540.03%

Shares held by insiders

Shares held by institutions

63.25%

Shares outstanding

59.2M

Short % of float

20.99%

Short % of shares

13.21%

Short ratio

6.1 days

Vor Biopharma Inc. (VOR)

Price

Financial snapshot

Fair-value bridge

Latest news · VOR

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All VOR indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on VOR

Frequently asked questions